Cisplatin plus paclitaxel chemotherapy with or without bevacizumab in postmenopausal women with previously untreated advanced cervical cancer: a retrospective study

Cisplatin plus paclitaxel chemotherapy with or without bevacizumab in postmenopausal women with previously untreated advanced cervical cancer: a retrospective study

Abstract Background The aim of this study was to assess the survival outcomes of cisplatin-paclitaxel chemotherapy plus bevacizumab (CPB) versus cisplatin-paclitaxel chemotherapy alone (CPA) in postmenopausal women with previously untreated advanced cervical cancer (CC). Methods Consecutive postmeno...

Full description

Bibliographic Details
Main Authors: Guanghua Chu, Xiangzhen Liu, Weiguang Yu, Meiji Chen, Lingyun Dong
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Cancer
Subjects:
Bevacizumab
Advanced
Cervical cancer
Chemotherapy
Survival
Online Access:https://doi.org/10.1186/s12885-021-07869-7

Similar Items

Similar Items